microbiome

Skip to content The CRC Digest Microbiota influences immunotherapy efficacy in MSI-H colorectal cancer Immune checkpoint inhibitors benefit patients with mismatch repair-deficient/microsatellite instability-high colorectal cancer, and gut microbiota appears to play a key role in treatment response. (Life Sciences) This content is informational only and does not constitute medical

Skip to content The CRC Digest ◇ Review highlights gut microbiota's role in immunotherapy response, especially for MSI-H tumors A comprehensive review evaluates how gut microbiota and microbial metabolites influence colorectal cancer development, the tumor microenvironment, and immunotherapy responses, with emphasis on strategies for proficient mismatch repair/microsatellite-stable tumors